13 drug(s) with this reaction
13,437 total reports
Dyspnoea has been reported as an adverse reaction across 13 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 13,437 adverse event reports mention dyspnoea in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with dyspnoea, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have dyspnoea listed in their FDA adverse event reports, sorted by report count:
In addition to dyspnoea, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
13 drug(s) manufactured by Amgen Inc have dyspnoea listed in their FDA adverse event reports: DENOSUMAB, APREMILAST, PEGFILGRASTIM, DARBEPOETIN ALFA, FILGRASTIM, and others.
There are a combined 13,437 reports of dyspnoea across 13 Amgen Inc drug(s) in the FDA adverse event database.